Hasil Pencarian - Brian Poligone

  • Menampilkan 1 - 8 hasil dari 8
Perbaiki Hasil
  1. 1
    Lysophosphatidic acid down-regulates human RIPK4 mRNA in keratinocyte- derived cell lines

    Lysophosphatidic acid down-regulates human RIPK4 mRNA in keratinocyte- derived cell lines oleh Lei Xu, Peter Bajorski, Brian Poligone

    Diterbitkan 2024-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Lysophosphatidic acid down-regulates human RIPK4 mRNA in keratinocyte- derived cell lines.

    Lysophosphatidic acid down-regulates human RIPK4 mRNA in keratinocyte- derived cell lines. oleh Lei Xu, Peter Bajorski, Brian Poligone

    Diterbitkan 2024-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    A Little Experience Goes a Long Way: Chlormethine/Mechlorethamine Treatment Duration as a Function of Clinician-Level Patient Volume for Mycosis Fungoides Cutaneous T-Cell Lymphoma (MF-CTCL)—A Retrospective Cohort Study

    A Little Experience Goes a Long Way: Chlormethine/Mechlorethamine Treatment Duration as a Function of Clinician-Level Patient Volume for Mycosis Fungoides Cutaneous T-Cell Lymphoma... oleh Christiane Querfeld, Theresa Pacheco, Bradley Haverkos, Gary Binder, James Angello, Brian Poligone

    Diterbitkan 2021-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    A role for NF-κB activity in skin hyperplasia and the development of keratoacanthomata in mice.

    A role for NF-κB activity in skin hyperplasia and the development of keratoacanthomata in mice. oleh Brian Poligone, Matthew S Hayden, Luojing Chen, Alice P Pentland, Eijiro Jimi, Sankar Ghosh

    Diterbitkan 2013-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Compatibility study of topical 0.25% hypericin (HyBryteTM) application in subjects with mycosis fungoides: Results of the HPN‐CTCL‐02 study

    Compatibility study of topical 0.25% hypericin (HyBryteTM) application in subjects with mycosis fungoides: Results of the HPN‐CTCL‐02 study oleh Carolina V. Alexander‐Savino, Adam Rumage, Christopher Pullion, Richard Straube, Christopher J. Schaber, Elaine S. Gilmore, Brian Poligone

    Diterbitkan 2024-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Evaluation and management of patients with early-stage mycosis fungoides who interrupt or discontinue topical mechlorethamine gel because of dermatitis

    Evaluation and management of patients with early-stage mycosis fungoides who interrupt or discontinue topical mechlorethamine gel because of dermatitis oleh Elaine S. Gilmore, MD, PhD, Carolina V. Alexander-Savino, BS, Catherine G. Chung, MD, Brian Poligone, MD, PhD

    Diterbitkan 2020-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    PB2358: PHASE 1-2 STUDY OF THE SAFETY, PK, PD, AND PRELIMINARY ACTIVITY OF TOLINAPANT IN COMBINATION WITH ORAL DECITABINE/CEDAZURIDINE AND ORAL DECITABINE/CEDAZURIDINE ALONE IN SUBJECTS WITH R/R PTCL

    PB2358: PHASE 1-2 STUDY OF THE SAFETY, PK, PD, AND PRELIMINARY ACTIVITY OF TOLINAPANT IN COMBINATION WITH ORAL DECITABINE/CEDAZURIDINE AND ORAL DECITABINE/CEDAZURIDINE ALONE IN SUB... oleh Jake Shortt, Brian Poligone, Vincent Ribrag, Pier Luigi Zinzani, Dima El-Sharkawi, Jan Walewski, Anca Prica, Laksmi Wilson, Sonia Souza, Harold Keer, Jason Taylor, Enrica Marchi

    Diterbitkan 2023-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    HyBryte™ use in early-stage cutaneous T-cell lymphoma

    HyBryte™ use in early-stage cutaneous T-cell lymphoma oleh Brian Poligone, Carolina V. Alexander-Savino, Ellen J. Kim, Aaron R. Mangold, Jennifer Desimone, Henry K. Wong, Adam T. Rumage, Oreola Donini, Andrea Haulenbeek, Christopher J. Schaber, Richard Straube, Christopher Pullion, Alain H. Rook

    Diterbitkan 2023-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: